Oxeco PLC Share Price London S.E.
Equities
OXE
GB00B1J5QT30
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- GBX | - |
|
12:32pm | Tissue Regenix eyes revenue and adjusted profit growth | AN |
14/06 | Tissue Regenix purchases Texas facility to generate cost savings | AN |
Sales 2024 * | 26.82M 34.76M 2.9B | Sales 2025 * | 30.72M 39.82M 3.32B | Capitalization | 52.71M 68.32M 5.7B |
---|---|---|---|---|---|
Net income 2024 * | - 0 0 | Net income 2025 * | - 0 0 | EV / Sales 2024 * | 2.06 x |
Net Debt 2024 * | 2.61M 3.38M 282M | Net Debt 2025 * | 3.81M 4.94M 413M | EV / Sales 2025 * | 1.84 x |
P/E ratio 2024 * |
-221
x | P/E ratio 2025 * |
88.4
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 52.08% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel Lee
CEO | Chief Executive Officer | 63 | 01/19/01 |
Kirsten Lund
DFI | Director of Finance/CFO | - | 01/10/01 |
David Cocke
DFI | Director of Finance/CFO | 58 | 21/21/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Trevor Phillips
BRD | Director/Board Member | 63 | 05/21/05 |
George Phillips
BRD | Director/Board Member | 64 | 05/21/05 |
Daniel Lee
CEO | Chief Executive Officer | 63 | 01/19/01 |
1st Jan change | Capi. | |
---|---|---|
+40.70% | 9.47B | |
+32.36% | 4.33B | |
-34.86% | 2.21B | |
-6.10% | 1.66B | |
-27.24% | 1.21B | |
-42.98% | 1.01B | |
-2.17% | 852M | |
-50.69% | 681M | |
-30.58% | 604M |
- Stock Market
- Equities
- TRX Stock
- OXE Stock